Your browser doesn't support javascript.
loading
Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia.
Rajapreyar, Indranee; Joly, Joanna; Tallaj, Jose; Pamboukian, Salpy V; Assad, Ayman Haj; Lenneman, Carrie; Litovsky, Silvio; Chatterjee, Arka; Hoopes, Charles; Lenneman, Andrew.
Afiliação
  • Rajapreyar I; Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
  • Joly J; Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
  • Tallaj J; Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
  • Pamboukian SV; Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
  • Assad AH; Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
  • Lenneman C; Division of Cardiovascular disease, University of Alabama at Birmingham, Birmingham.
  • Litovsky S; Department of Pathology, University of Alabama at Birmingham, Birmingham.
  • Chatterjee A; Division of Cardiovascular disease, University of Alabama at Birmingham, Birmingham.
  • Hoopes C; Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham.
  • Lenneman A; Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
Mayo Clin Proc Innov Qual Outcomes ; 5(1): 210-218, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33718795
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as multiple myeloma and amyloidosis. We describe 4 cases of PH likely due to pulmonary vascular involvement and myocardial deposition from light chain deposition disease, amyloidosis, and multiple myeloma. On the basis of our clinical experience and literature review, we propose screening for plasma cell dyscrasia in patients with heart failure with preserved ejection fraction, unexplained PH, and hematological abnormalities. We also recommend inclusion of cardiopulmonary screening in patients with monoclonal gammopathy of undetermined significance.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Idioma: En Revista: Mayo Clin Proc Innov Qual Outcomes Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Idioma: En Revista: Mayo Clin Proc Innov Qual Outcomes Ano de publicação: 2021 Tipo de documento: Article
...